|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Current systematic reviews and meta-analyses of COVID-19显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)has left a significant impact on the world's health,economic and political systems;as of November 20,2020,more than 57 million people have been infected worldwide,with over 1.3 million deaths.While the global spotlight is currently focused on combating this pandemic through means ranging from finding a treatment among existing therapeutic agents to inventing a vaccine that can aid in halting the further loss of life.AIM To collect all systematic reviews and meta-analyses published related to COVID-19 to better identify available evidence,highlight gaps in knowledge,and elucidate further meta-analyses and umbrella reviews that are yet to be performed.METHODS We explored studies based on systematic reviews and meta-analyses with the keyterms,including severe acute respiratory syndrome(SARS),SARS virus,coronavirus disease,COVID-19,and SARS coronavirus-2.The included studies were extracted from Embase,Medline,and Cochrane databases.The publication timeframe of included studies ranged between January 01,2020,to October 30,2020.Studies that were published in languages other than English were not considered for this systematic review.The finalized full-text articles are freely accessible in the public domain.RESULTS Searching Embase,Medline,and Cochrane databases resulted in 1906,669,and 19 results,respectively,that comprised 2594 studies.515 duplicates were subsequently removed,leaving 2079 studies.The inclusion criteria were systematic reviews or meta-analyses.860 results were excluded for being a review article,scope review,rapid review,panel review,or guideline that produced a total of 1219 studies.After screening articles were categorized,the included articles were put into main groups of clinical presentation,epi-demiology,screening and diagnosis,severity assessment,special populations,and treatment.Subsequently,there was a second subclassification into the following groups:gastrointestinal,cardiovascular,neurological,stroke,thrombosis,anosmia and dysgeusia,ocular manifestations,nephrology,cutaneous manifestations,D-dimer,lymphocyte,anticoagulation,antivirals,convalescent plasma,immunosuppressants,corticosteroids,hydroxychloroquine,renin-angiotensin-aldosterone system,technology,diabetes mellitus,obesity,pregnancy,children,mental health,smoking,cancer,and transplant.CONCLUSION Among the included articles,it is clear that further research is needed regarding treatment options and vaccines.With more studies,data will be less heterogeneous,and statistical analysis can be better applied to provide more robust clinical evidence.This study was not designed to give recommendations regarding the management of COVID-19. | Mahmoud Nassar Nso Nso Mostafa Alfishawy Anastasia Novikov Salim Yaghi Luis Medina Bahtiyar Toz Sofia Lakhdar Zarwa Idrees Yungmin Kim Dawa Ongyal Gurung Raheel S Siddiqui David Zheng Mariam Agladze Vikram Sumbly Jasmine Sandhu Francisco Cuevas Castillo Nadya Chowdhury Ravali Kondaveeti Sakil Bhuiyan Laura Guzman Perez Riki Ranat Carlos Gonzalez Harangad Bhangoo John Williams Alaa Eldin Osman Joyce Kong Jonathan Ariyaratnam Mahmoud Mohamed Ismail Omran Mariely Lopez Akwe Nyabera Ian Landry Saba Iqbal Anoosh Zafar Gondal Sameen Hassan Ahmed Daoud Bahaaeldin Baraka Theo Trandafirescu Vincent Rizzo | 2021 | World Journal of Virology2021，10，4： | 2 |
| 2 | ABO incompatibility in renal transplantation显示文摘ABO blood group incompatibility(ABO-I)was historically considered an absolute contraindication to kidney transplantation due to the significant risk of acute antibody-mediated rejection and early graft loss.Nevertheless,the urge to minimize the gap between the candidates’number on the waitlist for kidney transplants and the available kidney donors encourage investigation into finding ways to use organs from ABO-I kidney donors,especially in the era of using more potent immunosuppression therapies.This review aims to discuss a general overview of ABO-I kidney transplantation and the different protocols adopted by some transplant centers to meaningfully overcome this barrier. | Mahmoud Mohamed Tara Sweeney Duaa Alkhader Mahmoud Nassar Ahmed Alqassieh Sofia Lakhdar Nso Nso Tibor Fulop Ahmed Daoud Karim M Soliman | 2021 | World Journal of Transplantation2021，11，9： | 2 |
| 3 | Lubricating Oil Additives Based on Polyalkylpolyamines显示文摘 | Nehal S. Ahmed Amal M. Nassar | 2009 | International Journal of Polymeric Materials2009，，3： | 1 |
| 4 | Hydrothermal Synthesis of Cobalt Carbonates Using Different Counter Ions : An Efficient Precursor to Nano-sized Cobalt Oxide ( Co304 ) 显示文摘 | Nassar M Y Ahmed I S | 2011 | Polyhedron2011，30，15： | 1 |
| 5 | Laparoscopic transcystic bile duct exploration: the treatment of first choice for common bile duct stones显示文摘 | Faisal Hanif Zubir Ahmed M. Abdel Samie Ahmad H. M. Nassar | 2010 | Surgical Endoscopy2010，，7： | 1 |
| 6 | An eudesmanolide and a cartane from Ferula sinaica 显示文摘 | Ahmed AA Mohamed HA Nassar MI | 2001 | Phychem2001，57，： | 1 |
| 7 | Stability and rheology of heavy crude oil-in-water emulsion stabilized by an anionic-nonionic surfactant mixture显示文摘 | Ahmed N S Nassar A M Zaki N N | | 0，，5： | 1 |
| 8 | Stability and rheol ogy of heavy crude oil-in water emulsion stabilized by an an ionic-nonionic surfactant mixture显示文摘 | Ahmed N S Nassar A M Zaki N N | 1999 | Petroleum Sci Technol1999，17，56： | 1 |
| 9 | Laparoscopic cholecystectomy andthe umbilicus显示文摘 | Nassar AHM Ashkar KA Rashed AA | 1997 | Br J Surg1997，84，6： | 1 |
| 10 | Laparoscopic transcystic bile duct exploration: the treatment of first choice for common bile duct stones显示文摘 | Faisal Hanif Zubir Ahmed M. Abdel Samie Ahmad H. M. Nassar | 2010 | Surgical Endoscopy2010，，7： | 1 |
| 11 | Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis:A systematic review and meta-analysis显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)has been the most talked-about disease of the past few years.Patients with significant comorbidities have been at particular risk of adverse outcomes.This study looked at the outcomes and risk factors for adverse outcomes among patients on chronic hemodialysis for end-stage renal disease,a group of patients known to be particularly susceptible to infectious complications.AIM To assess outcomes and risk factors for adverse outcomes of COVID-19 infection among patients on chronic hemodialysis.METHODS We searched PubMed/MEDLINE,EMBASE,Reference Citation Analysis(http://gffzzb1f9d057b5954674spxwnqn60wqxq6509.ffgz.tsg.suse.edu.cn/)and Web of Science databases for relevant terms and imported the results into the Covidence platform.From there,studies were assessed in two stages for relevance and quality,and data from studies that satisfied all the requirements were extracted into a spreadsheet.The data was then analyzed descriptively and statistically.RESULTS Of the 920 studies identified through the initial database search,only 17 were included in the final analysis.The studies included in the analysis were mostly carried out during the first wave.We found that COVID-19 incidence among patients on hemodialysis was significant,over 10%in some studies.Those who developed COVID-19 infection were most likely going to be hospitalized,and over 1 in 5 died from the infection.Intensive care unit admission rate was lower than the infection lethality rate.Biochemical abnormalities and dyspnea were generally reported to be associated with adverse outcomes.CONCLUSION This systematic review confirms that patients on chronic hemodialysis are very high-risk individuals for COVID-19 infections,and a significant proportion was infected during the first wave.Their prognosis is overall much worse than in the general population,and every effort needs to be made to decrease their exposure. | Ivan Cancarevic Mahmoud Nassar Ahmed Daoud Hatem Ali Nso Nso Angelica Sanchez Avish Parikh Asma Ul Hosna Bhavana Devanabanda Nazakat Ahmed Karim M Soliman | 2022 | World Journal of Virology2022，11，5： | 1 |
| 12 | Sodium lignin sulfonate to stabilize heavy crude oil-in-water emulsions for pipeline transportation 显示文摘 | Zaki N N Ahmed N S Nassar A M | 2000 | Petroleum Science and Technology2000，18，1： | 1 |
| 13 | Synthesis of Some New Diazo Disperse Dyes and Their Application on Dyeing of Polyester显示文摘 | Ahmed Zaky Sayed Mahmoud Sayed Aboul-Fetouh Hesham Sayed Nassar | 2011 | Journal of Chemistry and Chemical Engineering2011，5，2： | 1 |
| 14 | Laparoscopic transcystic bile duct exploration: the treatment of first choice for common bile duct stones显示文摘 | Faisal Hanif Zubir Ahmed M. Abdel Samie Ahmad H. M. Nassar | 2010 | Surgical Endoscopy2010，，7： | 1 |
| 15 | Fludarabine-Based Conditioning Chemotherapy for Allogeneic Hematopoietic Stem Cell Transplantation in Acquired Severe Aplastic Anemia显示文摘 | Hazzaa Al-Zahrani Amr Nassar Fahad Al-Mohareb Fahad Al-Sharif Said Mohamed Khalid Al-Anazi Moosa Patel Walid Rasheed Abu Jafar Mohammed Saleh Mahmoud Bakr Shad Ahmed Khalid Ibrahim Fazal Hussain Naser Elkum Tusneem Elhassan Zubeir Nurgat Naeem Chaudhri Ma | 2011 | Biology of Blood and Marrow Transplantation2011，，5： | 1 |
| 16 | Hydrothermal synthesis of cobalt carbonates using different counter ions:An efficient precursor to nano-sized cobalt oxide(Co304)显示文摘 | NASSAR M Y AHMED I S | 2011 | Polyhedron2011，30，： | 1 |
| 17 | Formation of fluid heavy oil-in-water emulsions for pipeline transportation显示文摘 | Ahmed N S Nassar A M Zaki N N | 1999 | Fuel1999，78，5： | 1 |
| 18 | Synthesis,biological activity and dyeing performance of some novel azo disperse dyes incorporating pyrazolopyrimidines for dyeing of polyester fabrics显示文摘 | SAYED Ahmed Z Aboul-Fetouh Mahmoud S NASSAR Hesham S | 2012 | Journal of Molecular Structure2012，1010，： | 1 |
| 19 | Formation of fluid heavy oil - in - water emulsions for pipeline transportation corporate显示文摘 | Ahmed N S Nassar A M Zaki N N Gharieb H K | 1999 | Fuel1999，78，5： | 1 |
| 20 | Sesquiterpene coumatins from Ferula assafoetida L显示文摘 | Nassar M I Abu-mustafa E A Ahmed A A | 1995 | Pharmazie1995，50，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员